RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Immunodiagnostic Systems Holdings Stock

Immunodiagnostic Systems Holdings Employees 2024

Immunodiagnostic Systems Holdings Employees

0

Ticker

IDH.L

ISIN

GB00B01YZ052

WKN

A0D9MS

In 2024, Immunodiagnostic Systems Holdings employed 0 people, a 0% change from the 0 number of employees in the previous year.

Immunodiagnostic Systems Holdings Aktienanalyse

What does Immunodiagnostic Systems Holdings do?

IDS, Immunodiagnostic Systems Holdings PLC, is an English-American diagnostic company that specializes in the development, manufacture, and marketing of diagnostic tests for various applications. The company was founded in 1977 in Boldon, England and is headquartered in Tyne and Wear. IDS started with a focus on researching enzyme immunoassays (EIA) and has expanded its offerings to include radioimmunoassays and chemiluminescent tests. IDS operates in sectors such as endocrinology, clinical chemistry, hematology, and oncology, and is known as a leading provider of diagnostic test kits in many countries. The company offers over 400 tests, including reagents, calibrators, controls, and devices for more than 200 different parameters. IDS sells its products through an international network of branches, distributors, and authorized dealers in Asia, Europe, North America, South America, and the Middle East. The company has also established subsidiaries in the US and China to expand its offerings and drive growth in these regions. IDS's business model is focused on meeting customer needs for reliable, accurate, and fast diagnostic solutions. The company adheres to the highest quality standards and is committed to the continuous development and improvement of its products to enhance patient care and laboratory work worldwide. IDS has made a name for itself in the diagnostic industry in recent years and is a pioneer in developing tests for emerging applications such as autoimmune diseases and food intolerances. The company invests heavily in research and development and collaborates closely with academic partners and research institutions to identify and develop innovative diagnostic solutions. In summary, IDS is a leading diagnostic company operating in various applications and offering a wide range of diagnostic test solutions. The company has experienced strong growth in recent years and is committed to expanding its product range and offerings to meet the needs of patients and laboratories worldwide. Immunodiagnostic Systems Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Immunodiagnostic Systems Holdings's Employee Base

Immunodiagnostic Systems Holdings's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Immunodiagnostic Systems Holdings's operational capacity and future potential.

Year-to-Year Comparison

Assessing Immunodiagnostic Systems Holdings's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Immunodiagnostic Systems Holdings's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Immunodiagnostic Systems Holdings’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Immunodiagnostic Systems Holdings stock

How many employees does Immunodiagnostic Systems Holdings have this year?

Immunodiagnostic Systems Holdings has 0 undefined employees this year.

How many employees did Immunodiagnostic Systems Holdings have compared to the previous year?

Compared to the previous year, Immunodiagnostic Systems Holdings had 0% more employees.

What impact did the number of employees have on the company Immunodiagnostic Systems Holdings?

The number of employees has a direct impact on the efficiency and productivity of Immunodiagnostic Systems Holdings. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Immunodiagnostic Systems Holdings?

The number of employees can also have an impact on investors of Immunodiagnostic Systems Holdings, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Immunodiagnostic Systems Holdings affect the company?

An increase in equity of Immunodiagnostic Systems Holdings can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Immunodiagnostic Systems Holdings's equity affect the company?

A reduction in equity of Immunodiagnostic Systems Holdings can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Immunodiagnostic Systems Holdings?

Some factors that can influence the equity of Immunodiagnostic Systems Holdings include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Immunodiagnostic Systems Holdings so important for investors?

The equity of Immunodiagnostic Systems Holdings is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Immunodiagnostic Systems Holdings influence the company?

The number of employees at Immunodiagnostic Systems Holdings can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Immunodiagnostic Systems Holdings evolved in recent years?

In recent years, the number of employees at Immunodiagnostic Systems Holdings has changed by NaN.

How many employees does Immunodiagnostic Systems Holdings currently have?

Immunodiagnostic Systems Holdings currently has 0 undefined employees.

Why is the number of employees important for investors of Immunodiagnostic Systems Holdings?

The number of employees is important for investors of Immunodiagnostic Systems Holdings as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Immunodiagnostic Systems Holdings take to change the number of employees?

To change the number of employees, Immunodiagnostic Systems Holdings can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Immunodiagnostic Systems Holdings pay?

Over the past 12 months, Immunodiagnostic Systems Holdings paid a dividend of 0.02 GBP . This corresponds to a dividend yield of about 50.26 %. For the coming 12 months, Immunodiagnostic Systems Holdings is expected to pay a dividend of 0.02 GBP.

What is the dividend yield of Immunodiagnostic Systems Holdings?

The current dividend yield of Immunodiagnostic Systems Holdings is 50.26 %.

When does Immunodiagnostic Systems Holdings pay dividends?

Immunodiagnostic Systems Holdings pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Immunodiagnostic Systems Holdings?

Immunodiagnostic Systems Holdings paid dividends every year for the past 15 years.

What is the dividend of Immunodiagnostic Systems Holdings?

For the upcoming 12 months, dividends amounting to 0.02 GBP are expected. This corresponds to a dividend yield of 50.26 %.

In which sector is Immunodiagnostic Systems Holdings located?

Immunodiagnostic Systems Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Immunodiagnostic Systems Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Immunodiagnostic Systems Holdings from 8/14/2020 amounting to 0.019 GBP, you needed to have the stock in your portfolio before the ex-date on 7/16/2020.

When did Immunodiagnostic Systems Holdings pay the last dividend?

The last dividend was paid out on 8/14/2020.

What was the dividend of Immunodiagnostic Systems Holdings in the year 2023?

In the year 2023, Immunodiagnostic Systems Holdings distributed 0.007 GBP as dividends.

In which currency does Immunodiagnostic Systems Holdings pay out the dividend?

The dividends of Immunodiagnostic Systems Holdings are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Immunodiagnostic Systems Holdings

Our stock analysis for Immunodiagnostic Systems Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Immunodiagnostic Systems Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.